Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.36

€0.36

5.630%
0.0194
5.630%
-
 
06.06.25 / Tradegate WKN: A2JD8X / Symbol: AVIR / Name: Vaxart / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...
Your prediction

Vaxart Inc. Stock

A very strong showing by Vaxart Inc. today, with an increase of €0.019 (5.630%) compared to yesterday's price.
For the coming years our community has positive and negative things to say abot the Vaxart Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.

Pros and Cons of Vaxart Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Vaxart Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Vaxart Inc. 5.630% -6.519% -3.106% -51.354% -50.335% -89.541% -
Larimar Therapeutics Inc. 0.960% 5.528% -3.670% -75.723% -43.548% -8.696% -83.219%
aTyr Pharma Inc -3.020% 19.048% 45.161% 174.390% 27.119% 71.168% 32.353%
Achieve Life Sciences Inc. -9.500% 13.668% 44.714% -31.348% -7.854% -47.649% -53.628%

Comments

Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for AVIR provided by MarketBeat
Show more

Buy Vaxart Inc.
Show more

Buy Vaxart Inc.
Show more